Guardion Health Sciences IPO Info

Company Name: Guardion Health Sciences
Stock Symbol: GHSI
Exchange: NASDAQ
Status: Priced
IPO Date: 4/5/2019
IPO Price: 4.00 (-94.50%)

Underwriters

WallachBeth Capital

Amount of Offering: N/A
Number of Shares Offered: 1.25 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A

Company Description

Guardion is an ocular health sciences company that develops, formulates and distributes condition-specific medical foods supported by evidence-based protocols, with an initial medical food product that addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (“AMD”), and a significant component of functional vision performance. Guardion Health Sciences, Inc. has also developed a proprietary medical device, the MapcatSF®, which accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment.

News Headlines

• Guardion Health Sciences (GHSI) IPO Opens Lower